Mar 04, 2025
Nikon Instruments Announces Moffitt Cancer Center As Newest Nikon Center of Excellence
Feb 01, 2021
Tampa Bay Buccaneers Defensive End William Gholston Funds Cancer Health Disparities Research at Moffitt Cancer Center
Dec 18, 2020
AutoNation Donates $62,000 for Moffitt Cancer Center
Aug 20, 2020
Moffitt Cancer Center Names Patrick Hwu, M.D., as President and CEO
Feb 25, 2020
Oncologie, Inc. Announces Collaboration with Moffitt Cancer Center to Advance the Development of Precision Medicine for the Treatment of Gastric and Gastrointestinal Cancers
Feb 12, 2020
Anixa Biosciences and Moffitt Cancer Center Announce Completion of Viral Vector Reformulation for CAR-T Program
Feb 03, 2020
Olympic Gold Medalist Scott Hamilton Releases Children's Book to Help Parents Talk to Kids about Cancer
Oct 23, 2019
Laboratory for Advanced Medicine Appoints to its Board of Directors Dr. Alan List, President and CEO, Moffitt Cancer Center
Oct 03, 2019
ThreatWarrior and Moffitt Cancer Center work together to bring Next-Generation Cybersecurity to the Health Care Industry
Jun 24, 2019
Craneware Showcases Use of Artificial Intelligence (AI) to Improve Financial Performance at HFMA Annual Conference 2019
Feb 13, 2019
Anixa Biosciences to Present at Moffitt Cancer Center's Business of Biotech Conference
Oct 22, 2018
Moffitt Cancer Center and Anixa Biosciences Announce Completion of Pre-IND Meeting with FDA for CAR-T Therapy
Jun 26, 2018
ITUS Accelerates Schedule for its CAR T Therapy and Provides Update
Dec 10, 2017
New Data for FDA-Approved CAR T Therapy Show Significant Remission Rates in 42% of Non-Hodgkin Lymphoma Patients
Dec 04, 2017
Moffitt Cancer Center Treats First U.S. Patient with Newly FDA-Approved CAR-T Therapy
Nov 20, 2017
ITUS Enters CAR-T Research Alliance with Moffitt Cancer Center
Oct 18, 2017
FDA Approves Yescarta(TM), Revolutionary CAR-T Immunotherapy for Non-Hodgkin's Lymphoma Patients
Oct 12, 2017
Stand Up To Cancer Awards Moffitt $2.67 Million to Study New Lung Cancer Immunotherapy